Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Anatara Lifesciences Ltd ( (AU:ANR) ) has shared an update.
Anatara Lifesciences Ltd reported a 35% increase in net loss after tax for the year ending June 30, 2025, amounting to $1,954,702. Despite the financial setback, the company’s operations and activities continue without changes in controlled entities, and the financial statements received an unqualified audit opinion, albeit with an emphasis on going concern.
More about Anatara Lifesciences Ltd
Anatara Lifesciences Ltd operates in the biotechnology industry, focusing on developing and commercializing products for gastrointestinal health. The company targets both human and animal health markets, aiming to address unmet medical needs with innovative solutions.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$1.92M
For a thorough assessment of ANR stock, go to TipRanks’ Stock Analysis page.